Market Chatter: Sanofi Said to Consider Takeover of Insmed

MT Newswires Live11-19 23:21

Sanofi (SNY) is mulling an acquisition of US drugmaker Insmed (INSM), Bloomberg reported Thursday, citing people familiar with the matter.

Sanofi is in talks with advisers as it evaluates a potential deal for Insmed, the shares of which have dropped about 40% over the last year, giving it a market value of about $26.6 billion, the report said, citing the people.

Deliberations are underway and any deal could still be weeks away, the report said, citing the people.

Sanofi and Insmed didn't immediately reply to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 45.46, Change: -1.67, Percent Change: -3.53

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment